{
    "2018-09-27": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Look at Abbott Laboratories’ Valuation Trend",
                "features": {
                    "keywords": [
                        "valuation trend",
                        "Abbott Laboratories"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "Analysts’ Most Recent Recommendations on ABT",
                "features": {
                    "keywords": [
                        "analysts",
                        "recommendations",
                        "ABT"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-20",
                "original_text": "Abbott Laboratories Continues Its Bull Run with a Record High",
                "features": {
                    "keywords": [
                        "bull run",
                        "record high",
                        "Abbott Laboratories"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-12",
                "original_text": "Abbott's Troponin-I Wins CE Mark, Vascular Arm Gets a Revamp",
                "features": {
                    "keywords": [
                        "Troponin-I",
                        "CE Mark",
                        "vascular arm",
                        "revamp"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-05",
                "original_text": "Abbott Labs' Test for Heart Attack Risk Granted With CE Mark",
                "features": {
                    "keywords": [
                        "heart attack risk",
                        "CE Mark",
                        "Abbott Labs"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-18",
                "original_text": "New Research Coverage Highlights CyberArk Software, Mercer International, American Airlines Group, Abbott Laboratories, Open Text, and The Kroger — Consolidated Revenues, Company Growth, and Expectations for 2018",
                "features": {
                    "keywords": [
                        "research coverage",
                        "consolidated revenues",
                        "company growth",
                        "expectations",
                        "Abbott Laboratories"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}